DiaMedica Therapeutics (DMAC) FCF Margin (2018)
DiaMedica Therapeutics' FCF Margin history spans 1 years, with the latest figure at 371.8% for Q3 2018.
- For Q3 2018, FCF Margin changed N/A year-over-year to 371.8%; the TTM value through Jun 2019 reached 1950.2%, changed N/A, while the annual FY2025 figure was 291020.0%, 22601706.0% up from the prior year.
- FCF Margin reached 371.8% in Q3 2018 per DMAC's latest filing.
- In the past five years, FCF Margin ranged from a high of 371.8% in Q3 2018 to a low of 371.8% in Q3 2018.